To hasten the routine use of in-vivo molecular
imaging of small animals for drug discovery and
development, NeuroPhysics is actively seeking
researchers for strategic partnership. Substantial
discounts on MollyQ systems are available for
those who qualify.
We invite discussions with Contract Research
Organizations (CRO), academic institutions and
pharmaceutical company research divisions to prove
MollyQ’s usefulness during the lead
optimization phase of drug discovery. In particular,
we are interested in animal pharmacokinetics (PK),
pharmacodynamics (PD), and absorption, distribution,
metabolism, and excretion (ADME) studies for central
nervous system (CNS) and oncology drugs. Our
objective is to understand the nature and extent of
quantification necessary to increase the throughput
of these studies and to thus accelerate the drug
discovery process.
"NeuroPhysics is open to partnerships with
companies that complement our products and
technologies."
If you are interested in becoming a strategic
partner, please
contact Hugh A. Stoddart.